Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02286973Phase 1Unknown
Phase 1, randomised, double-blind trial of tranexamic acid in hemorrhage (4 arms), sponsored by Seoul National University Hospital. Primary endpoint: Change in Hemoglobin at 5 days. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02286973.